Work

A phase 3 trial evaluating efficacy and safety of lenvatinib in combination with pembrolizumab in patients with advanced endometrial cancer.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.tps5607

Authors: Vicky Makker, Antonio Casado Herraez, Carol Aghajanian, Keiichi Fujiwara, Sandro Pignata, Richard T. Penson, Corina E. Dutcus, Matthew Guo, Lea Dutta, Robert Orlowski, Alan Smith, David S. Miller

Institutions: Memorial Sloan Kettering Cancer Center, Hospital Clínico San Carlos, Saitama International Medical Center, Saitama Medical University, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Harvard University, Eisai (United States), Merck & Co., Inc., Rahway, NJ, USA (United States), Eisai (United Kingdom), The University of Texas Southwestern Medical Center

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947256982

Cites:

Cited by: 10

Related to: 10